DESIGN, DOCKING AND SYNTHESIS OF NOVEL BROMO ISATIN INCORPORATED ISOXAZOLE DERIVATIVES AS VEGFR-2 INHIBITORS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2019, Vol 11, Issue 4
Abstract
Objective: To design, synthesize, in vitro Vascular Endothelial Growth Factor Receptor (VEGFR-2) assay, antiproliferative activity an Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) studies of some novel bromoisatin incorporated isoxazole derivatives. Methods: Designed compounds were synthesized by the condensation of different 3-aryl-5-methylisoxazole-4-carbohydrazides (5a-h) with 5-bromoisatin to give the target molecules. To predict the affinity and activity of the ligand molecule the docking program GOLD 3.1 was employed to generate different bioactive binding poses of designing molecules at the active site of protein VEGFR-2. All the synthesized compounds were characterized based on the spectral and elemental analysis data. Antiproliferative activity performed against Human Umbilical vein endothelial cells (HUVEC cell line). Results: All the synthesized compounds showed the characteristic peaks in FTIR,1H, C[13]NMR and Mass spectral analysis. In molecular docking, all the synthesized compounds (6a-j) exhibited high fitness scores with minimum three bonding interaction with the active site VEGFR-2 kinase. In in-vitro, VEGFR-2 kinase assay, compounds 6a, 6b, 6d and 6e exhibited more than 70% inhibition at a single dose concentration of 5μM. In antiproliferative assay against HUVEC cell lines, compounds 6d and 6e exhibited potent activity with IC50 values in nanomolar concentrations. ADMET results of 6a, 6b, 6d and 6e are quite promising with least hepatotoxicity and good bioavailability. Conclusion: The derivatives were synthesized in quantitative yields. New derivatives posses antiproliferative activity, least hepatotoxicity and good bioavailability.
Authors and Affiliations
RADHIKA T. , SAISREE K. , HARINADHA BABU V.
Keywords
Related Articles
- EP ID EP565389
- DOI 10.22159/ijpps.2019v11i4.31933
- Views 126
- Downloads 0
FORMULATION AND OPTIMIZATION OF SOLID SELF-NANOEMULSIFYING SYSTEM USING POROUS CARRIERS FOR ORAL DELIVERY OF CINNARIZINE
Objective: The present study aims to utilize the nanotechnology technique to formulate the Cinnarizine (CNZ) in the form of solid self-nano emulsifying system to enhance the dissolution and hence the bioavailability.Meth...
SYNTHESIS, CHARACTERIZATION AND EVALUATION OF NOVEL 6- SUBSTITUTED BENZIMIDAZOLE-2-CARBAMATES AS POTENTIAL ANTIMICROBIAL AGENTS
Objective: The aim of the present work was to synthesize and characterize a series of 6- substituted benzimidazole-2-carbamic acid derivatives and evaluate them for antimicrobial activity.Methods: A novel series of 6-sub...
REACTIVE OXYGEN AND NITROGEN SPECIES SCAVENGING AND ANTICANCER POTENTIAL OF CISSUS QUADRANGULARIS L. AGAINST EAC CELL LINE
Objective: To investigate the in vitro antioxidant and anticancer activity of chloroform and ethanol extracts of Cissus quadranqularis L. leaves.Methods: Phytochemicals were analysed by using standard methods. In Vitro a...
KINETICS AND MECHANISM OF OXIDATION OF AN ANTIARRHYTHMIC DRUG PROCAINAMIDE HYDROCHLORIDE BY MN (VII) IN AQUEOUS SULPHURIC ACID MEDIUM: A STOPPED FLOW TECHNIQUE
Objective: To understand the kinetics and mechanism of oxidation of procainamide hydrochloride by Mn(VII) in aqueous sulfuric acid medium at 298K and at constant ionic strength, I= 3.0×10-3 mol dm-3 and to identify its...
NIOSOME-ENCAPSULATED CLOMIPRAMINE FOR TRANSDERMAL CONTROLLED DELIVERY
ABSTRACTClomipramine (CLM) is a highly selective inhibitor of serotonin reuptake antidepressant. The objective of the present research was to decrease the extensive first-pass metabolism of the drug in the liver by devel...